Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Adenovirus-delivered wwox inhibited lung cancer growth in vivo in a mouse model

Abstract

Lung cancer is the most prevalent and deadly malignancy worldwide. This study investigated the possibility of inhibiting lung cancer in vivo with adenovirus-delivered WW domain-containing oxidoreductase (wwox). The lung cancer model was established by inoculating A549 lung cancer cells into the pleural space of nude mice. The control or wwox adenovirus was injected into the pleural space 7 days after cell inoculation and 14 days after first injection. The tumor number and burdens were measured 2 weeks after second virus injection. The carcinoembryonic antigen (CEA) and alpha-feto protein (AFP) levels in pleural effusion were analyzed by enzyme-linked immunosorbent assay. Apoptosis, proliferation and angiogenesis of tumor cells were assessed by terminal deoxinucleotidyl transferase-mediated dUTP-fluorescein nick end labeling assay, proliferating cell nuclear antigen (PCNA) and CD31 staining, respectively. Ectopic wwox significantly reduced both the number and size of lung tumors accompanied by substantially lower CEA and AFP levels in pleural effusion. The expression levels of Bcl2, Bcl-xL, vascular endothelial growth factor, PCNA-positive and CD31-positive cells in the tumors were significantly decreased, whereas levels of p21 and p73 and apoptotic cells markedly increased in mice receiving the wwox virus. These data demonstrated that wwox delivered by adenovirus was able to inhibit the growth of lung cancer in vivo, indicating the potential of using wwox as a gene therapy agent for lung cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.

    Article  PubMed  Google Scholar 

  2. Teng XD . [World Health Organization classification of tumours, pathology and genetics of tumours of the lung]. Zhonghua Bing Li Xue Za Zhi 2005; 34: 544–546 (in Chinese).

    PubMed  Google Scholar 

  3. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM . WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 2000; 60: 2140–2145.

    CAS  PubMed  Google Scholar 

  4. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K et al. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 2001; 61: 8068–8073.

    CAS  PubMed  Google Scholar 

  5. Lewandowska U, Zelazowski M, Seta K, Byczewska M, Pluciennik E, Bednarek AK . WWOX, the tumour suppressor gene affected in multiple cancers. J Physiol Pharmacol 2009; 60 (Suppl 1): 47–56.

    PubMed  Google Scholar 

  6. Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M et al. WWOX expression in different histologic types and subtypes of non-small cell lung cancer. Clin Cancer Res 2007; 13: 884–891.

    Article  CAS  PubMed  Google Scholar 

  7. Baykara O, Demirkaya A, Kaynak K, Tanju S, Toker A, Buyru N . WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC). Tumour Biol 2010; 31: 315–320.

    Article  CAS  PubMed  Google Scholar 

  8. Yang L, Liu B, Huang B, Deng J, Li H, Yu B et al. A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese. Hum Mol Genet 2013; 22: 1886–1894.

    Article  CAS  PubMed  Google Scholar 

  9. Bleau AM, Freire J, Pajares MJ, Zudaire I, Anton I, Nistal-Villán E et al. New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations. Int J Cancer 2014; 135: 2516–2527.

    Article  PubMed  Google Scholar 

  10. Becker S, Markova B, Wiewrodt R, Hoffarth S, Hähnel PS, Pleiner S et al. Functional and clinical characterization of the putative tumor suppressor WWOX in non-small cell lung cancer. J Thorac Oncol 2011; 6: 1976–1983.

    Article  PubMed  Google Scholar 

  11. Zhang P, Jia R, Ying L, Liu B, Qian G, Fan X et al. WWOX-mediated apoptosis in A549 cells mainly involves the mitochondrial pathway. Mol Med Rep 2012; 6: 121–124.

    PubMed  Google Scholar 

  12. Kimura M, Takenobu H, Akita N, Nakazawa A, Ochiai H, Shimozato O et al. Bmi1 regulates cell fate via tumor suppressor WWOX repression in small-cell lung cancer cells. Cancer Sci 2011; 102: 983–990.

    Article  CAS  PubMed  Google Scholar 

  13. Lin JT, Li HY, Chang NS, Lin CH, Chen YC, Lu PJ . WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase. Cell Cycle 2015; 14: 408–416.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gourley C, Paige AJ, Taylor KJ, Ward C, Kuske B, Zhang J et al. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Res 2009; 69: 4835–4842.

    Article  CAS  PubMed  Google Scholar 

  15. Yan HC, Xu J, Fang LS, Qiu YY, Lin XM, Huang HX et al. Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cells. Oncol Lett 2015; 9: 1614–1620.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Amelio I, Inoue S, Markert EK, Levine AJ, Knight RA, Mak TW et al. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation. Proc Natl Acad Sci USA 2015; 112: 226–231.

    Article  CAS  PubMed  Google Scholar 

  17. Stantic M, Sakil HA, Zirath H, Fang T, Sanz G, Fernandez-Woodbridge A et al. TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activity. Proc Natl Acad Sci USA 2015; 112: 220–225.

    Article  CAS  PubMed  Google Scholar 

  18. Harris AL . Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38–47.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the 11th Annual ‘Six Talent Summit’ Grants of Jiangsu province (2014-WSW-064) and Wuxi Municipal Health Bureau General Grants (ML201209).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Q You.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Y., Shou, F., Zhang, H. et al. Adenovirus-delivered wwox inhibited lung cancer growth in vivo in a mouse model. Cancer Gene Ther 23, 1–6 (2016). https://doi.org/10.1038/cgt.2015.56

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2015.56

This article is cited by

Search

Quick links